Raymond James Raises Sabra Health Care REIT (SBRA) Price Target to $24.00

Share on StockTwits

Sabra Health Care REIT (NASDAQ:SBRA) had its price objective hoisted by Raymond James from $22.00 to $24.00 in a research report released on Friday. Raymond James currently has a buy rating on the real estate investment trust’s stock.

A number of other analysts also recently issued reports on SBRA. ValuEngine downgraded shares of Sabra Health Care REIT from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. BidaskClub upgraded shares of Sabra Health Care REIT from a sell rating to a hold rating in a report on Wednesday, May 2nd. Cantor Fitzgerald restated a buy rating and set a $25.00 price objective on shares of Sabra Health Care REIT in a report on Wednesday, May 9th. JMP Securities raised their price objective on shares of Sabra Health Care REIT from $19.00 to $21.00 and gave the stock an outperform rating in a report on Monday, May 14th. Finally, TheStreet upgraded shares of Sabra Health Care REIT from a c+ rating to a b- rating in a report on Wednesday, June 6th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the stock. Sabra Health Care REIT currently has a consensus rating of Hold and a consensus price target of $22.73.

NASDAQ SBRA opened at $23.18 on Friday. Sabra Health Care REIT has a 52-week low of $15.77 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 1.00, a current ratio of 3.16 and a quick ratio of 3.16. The stock has a market cap of $3.94 billion, a P/E ratio of 9.60, a P/E/G ratio of 2.67 and a beta of 0.70.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, August 8th. The real estate investment trust reported $1.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.75. Sabra Health Care REIT had a net margin of 62.60% and a return on equity of 11.21%. The business had revenue of $166.31 million during the quarter, compared to the consensus estimate of $166.62 million. equities research analysts anticipate that Sabra Health Care REIT will post 2.51 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 31st. Stockholders of record on Saturday, August 18th will be paid a $0.45 dividend. The ex-dividend date of this dividend is Thursday, August 16th. This represents a $1.80 annualized dividend and a dividend yield of 7.77%. Sabra Health Care REIT’s payout ratio is 74.07%.

Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. boosted its position in shares of Sabra Health Care REIT by 2.3% in the first quarter. BlackRock Inc. now owns 26,146,828 shares of the real estate investment trust’s stock valued at $461,491,000 after acquiring an additional 577,060 shares during the period. LSV Asset Management boosted its position in shares of Sabra Health Care REIT by 10.8% in the second quarter. LSV Asset Management now owns 3,613,896 shares of the real estate investment trust’s stock valued at $78,529,000 after acquiring an additional 351,516 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Sabra Health Care REIT by 3.2% in the second quarter. Dimensional Fund Advisors LP now owns 2,731,650 shares of the real estate investment trust’s stock valued at $59,360,000 after acquiring an additional 84,833 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Sabra Health Care REIT by 0.5% in the second quarter. Bank of New York Mellon Corp now owns 2,663,709 shares of the real estate investment trust’s stock valued at $57,881,000 after acquiring an additional 12,607 shares during the period. Finally, River Road Asset Management LLC boosted its position in shares of Sabra Health Care REIT by 4.1% in the second quarter. River Road Asset Management LLC now owns 2,138,167 shares of the real estate investment trust’s stock valued at $46,462,000 after acquiring an additional 84,007 shares during the period. Hedge funds and other institutional investors own 87.82% of the company’s stock.

Sabra Health Care REIT Company Profile

As of March 31, 2018, Sabra's investment portfolio included 515 real estate properties held for investment (consisting of (i) 380 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), five assets held for sale, one investment in a direct financing lease, 21 investments in loans receivable (consisting of (i) two mortgage loans, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 15 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Featured Article: Fundamental Analysis – How It Helps Investors

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply